Issue 4, 2020

Correction: Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial

Abstract

Correction for ‘Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial’ by Song Lin et al., Food Funct., 2020, 11, 370–377.

Associated articles

Article information

Article type
Correction
Submitted
24 Mar 2020
Accepted
24 Mar 2020
First published
14 Apr 2020
This article is Open Access
Creative Commons BY license

Food Funct., 2020,11, 3751-3751

Correction: Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial

S. Lin, S. Zhao, J. Liu, J. Zhang, C. Zhang, H. Hao, Y. Sun, J. Cai, Y. Yang, Y. Ma, Y. Li, J. Wang and A. Ma, Food Funct., 2020, 11, 3751 DOI: 10.1039/D0FO90017F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements